Trial no.:
|
PACTR201807311514045 |
Date of Approval:
|
30/07/2018 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
quadratus lumborum block versus ilioinguinal nerve block |
Official scientific title |
Analgesic efficacy of ultrasound guided quadratus lumborum block versus ilioinguinal nerve block following pediatric open inguinal hernia repair |
Brief summary describing the background
and objectives of the trial
|
Ultrasound guided ilioinguinal (hypogastric) nerve block is a commonly used and effective postoperative analgesic technique for inguinal surgery. It classically involves blockade of the ilioinguinal and iliohypogastric nerve terminations of the 1st lumbar nerve root of the lumbar plexus anteromedial to the anterior superior iliac spine (ASIS). 1
The technique presents two challenges. First, the muscles of the abdominal wall (external and internal oblique, transversus abdominis) can be difficult to image, and many operators experience difficulty with local anesthetic placement using the out-of-plane technique at this location. 2
The Transversus Abdominis Plane (TAP) block has been used for postoperative analgesia for abdominal and pelvic surgical procedures. Nevertheless, the anterior approach to the TAP block has shown limited analgesic effect due to its short duration (up to 10 h) and mostly parietal pain relief profile.3,4 The posterior approach, or quadratus lumborum (QL) block, first described in 2007 by Blanco, demonstrated a spread to the paravertebral space, thus leading to a more extensive and long lasting block, with the potential to provide visceral pain relief.5
The aim of the current study is to compare the analgesic efficacy of ultrasound guided quadratus lumborum block versus ilioinguinal nerve block in pediatric patients undergoing open inguinal hernia repair.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Paediatrics |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/08/2018 |
Actual trial start date |
04/09/2018 |
Anticipated date of last follow up |
01/02/2019 |
Actual Last follow-up date |
26/04/2020 |
Anticipated target sample size (number of participants) |
90 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|